🚀 VC round data is live in beta, check it out!
Massmedica Valuation Multiples
Discover revenue and EBITDA valuation multiples for Massmedica and similar public comparables like Modne Zakupy, Monivent, Profusa, Nuwellis and more.
Massmedica Overview
About Massmedica
Massmedica SA is operating in the areas of reconstructive, regenerative, anti-aging and aesthetic medicine. It deals in the distribution of implants and other medical materials used in the treatment of diseases of the musculoskeletal system and in regenerative medicine.
Founded
2011
HQ
Employees
N/A
Website
Sectors
Financials (FY)
EV
$5M
Massmedica Financials
Massmedica reported last fiscal year revenue of $9M and EBITDA of $497K.
In the same fiscal year, Massmedica generated $4M in gross profit, $497K in EBITDA, and $121K in net income.
Massmedica P&L
In the most recent fiscal year, Massmedica reported revenue of $9M and EBITDA of $497K.
Massmedica expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $9M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $4M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 40% | XXX | XXX | XXX |
| EBITDA | — | XXX | $497K | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 6% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 5% | XXX | XXX | XXX |
| Net Profit | — | XXX | $121K | XXX | XXX | XXX |
| Net Margin | — | XXX | 1% | XXX | XXX | XXX |
| Net Debt | — | — | $2M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Massmedica Stock Performance
Massmedica has current market cap of $3M, and enterprise value of $5M.
Market Cap Evolution
Massmedica's stock price is $1.15.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $5M | $3M | 0.1% | XXX | XXX | XXX | $0.05 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMassmedica Valuation Multiples
Massmedica trades at 0.6x EV/Revenue multiple, and 10.1x EV/EBITDA.
Massmedica Financial Valuation Multiples
As of April 20, 2026, Massmedica has market cap of $3M and EV of $5M.
Equity research analysts estimate Massmedica's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Massmedica has a P/E ratio of 23.0x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $3M | XXX | $3M | XXX | XXX | XXX |
| EV (current) | $5M | XXX | $5M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 0.6x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 10.1x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 12.4x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 1.4x | XXX | XXX | XXX |
| P/E | — | XXX | 23.0x | XXX | XXX | XXX |
| EV/FCF | — | XXX | (381.7x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Massmedica Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Massmedica Margins & Growth Rates
Massmedica's revenue in the last fiscal year declined by (1%).
Massmedica Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (1%) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 6% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (12%) | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 35% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Massmedica Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Massmedica | XXX | XXX | XXX | XXX | XXX | XXX |
| Modne Zakupy | XXX | XXX | XXX | XXX | XXX | XXX |
| Monivent | XXX | XXX | XXX | XXX | XXX | XXX |
| Profusa | XXX | XXX | XXX | XXX | XXX | XXX |
| Nuwellis | XXX | XXX | XXX | XXX | XXX | XXX |
| VibroSense Dynamics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Massmedica M&A Activity
Massmedica acquired XXX companies to date.
Last acquisition by Massmedica was on XXXXXXXX, XXXXX. Massmedica acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Massmedica
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialMassmedica Investment Activity
Massmedica invested in XXX companies to date.
Massmedica made its latest investment on XXXXXXXX, XXXXX. Massmedica invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Massmedica
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Massmedica
| When was Massmedica founded? | Massmedica was founded in 2011. |
| Where is Massmedica headquartered? | Massmedica is headquartered in Poland. |
| Is Massmedica publicly listed? | Yes, Massmedica is a public company listed on Warsaw Stock Exchange. |
| What is the stock symbol of Massmedica? | Massmedica trades under MSM ticker. |
| When did Massmedica go public? | Massmedica went public in 2019. |
| Who are competitors of Massmedica? | Massmedica main competitors are Modne Zakupy, Monivent, Profusa, Nuwellis. |
| What is the current market cap of Massmedica? | Massmedica's current market cap is $3M. |
| What is the current revenue of Massmedica? | Massmedica's last fiscal year revenue is $9M. |
| What is the current EV/Revenue multiple of Massmedica? | Current revenue multiple of Massmedica is 0.6x. |
| Is Massmedica profitable? | No, Massmedica is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.